Trial · NCT02338973
Results by group677
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 677
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number and Severity of IP-related AEs | Interferon Gamma-1b | Severity: Mild | 3 | adverse events related to IP | |
| Number and Severity of IP-related AEs | Interferon Gamma-1b | Severity: Severe | 1 | adverse events related to IP | |
| Number of Participants Who Withdrew | Interferon Gamma-1b | 0 | Participants | ||
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Baseline in Study Eye | Participant 001 | 77 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Baseline in Fellow Eye | Participant 001 | 80 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Day 1 in Study Eye | Participant 001 | 76 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Day 1 in Fellow Eye | Participant 001 | 79 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | Difference in BCVA at Day 1 From Baseline in Study Eye | Participant 001 | -1 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | Difference in BCVA at Day 1 From Baseline in Fellow Eye | Participant 001 | -1 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Baseline in Study Eye | Participant 002 | 39 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Baseline in Fellow Eye | Participant 002 | 61 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Day 1 in Study Eye | Participant 002 | 32 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Day 1 in Fellow Eye | Participant 002 | 62 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | Difference in BCVA at Day 1 From Baseline in Study Eye | Participant 002 | -7 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | Difference in BCVA at Day 1 From Baseline in Fellow Eye | Participant 002 | 1 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Baseline in Study Eye | Participant 003 | 69 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Baseline in Fellow Eye | Participant 003 | 76 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Day 1 in Study Eye | Participant 003 | 74 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | BCVA at Day 1 in Fellow Eye | Participant 003 | 70 | letters read | |
| Change in Best Corrected Visual Acuity (BCVA) From Baseline as Compared to Day 1 | Difference in BCVA at Day 1 From Baseline in Study Eye | Participant 003 | 5 | letters read |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02338973/results